152 related articles for article (PubMed ID: 12205795)
1. [Biphosphonates in children: present and future].
Kone Paut I; Gennari JM; Retornaz K; Jouve JL; Bollini G
Arch Pediatr; 2002 Aug; 9(8):836-42. PubMed ID: 12205795
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates use in children.
Sebestyen JF; Srivastava T; Alon US
Clin Pediatr (Phila); 2012 Nov; 51(11):1011-24. PubMed ID: 22935217
[TBL] [Abstract][Full Text] [Related]
3. [Biphosphonates in oncology].
Khosravi Shahi P; Díaz Muñoz de la Espada V
An Med Interna; 2005 Nov; 22(11):544-7. PubMed ID: 16454591
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy.
Li B; Ling Chau JF; Wang X; Leong WF
J Cell Biochem; 2011 May; 112(5):1229-42. PubMed ID: 21465521
[TBL] [Abstract][Full Text] [Related]
5. Etidronate for hypercalcemia of malignancy and osteoporosis.
Horowitz E; Miller JL; Rose LI
Am Fam Physician; 1991 Jun; 43(6):2155-9. PubMed ID: 1904188
[TBL] [Abstract][Full Text] [Related]
6. The role of bisphosphonates in diseases of childhood.
Srivastava T; Alon US
Eur J Pediatr; 2003 Nov; 162(11):735-51. PubMed ID: 14523647
[TBL] [Abstract][Full Text] [Related]
7. Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease.
Heidenreich A; Ohlmann CH
Expert Rev Anticancer Ther; 2004 Dec; 4(6):991-1005. PubMed ID: 15606328
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates: from grandparents to grandchildren.
Srivastava T; Alon US
Clin Pediatr (Phila); 1999 Dec; 38(12):687-702. PubMed ID: 10618761
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic use of bisphosphonates.
Compston JE
BMJ; 1994 Sep; 309(6956):711-5. PubMed ID: 7950525
[No Abstract] [Full Text] [Related]
10. Bisphosphonates and primary hyperparathyroidism.
Rodan GA
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N150-3. PubMed ID: 12412793
[TBL] [Abstract][Full Text] [Related]
11. [Bone hyperresorption in multiple myeloma].
Beaudreuil J; Orcel P
Presse Med; 2000 Mar; 29(9):492-7. PubMed ID: 10745943
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in the treatment of disorders of mineral metabolism.
Singer FR; Minoofar PN
Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
[TBL] [Abstract][Full Text] [Related]
13. [Development of bisphosphonates].
Nakatsuka K
Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211
[TBL] [Abstract][Full Text] [Related]
14. Biphosphonates.
Allgrove J
Arch Dis Child; 1997 Jan; 76(1):73-5. PubMed ID: 9059169
[No Abstract] [Full Text] [Related]
15. Diphosphonates. Experimental and clinical aspects.
Russell RG; Smith R
J Bone Joint Surg Br; 1973 Feb; 55(1):66-86. PubMed ID: 4632759
[No Abstract] [Full Text] [Related]
16. Therapy of malignancy-associated hypercalcemia: 1983.
Stewart AF
Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
[TBL] [Abstract][Full Text] [Related]
17. [Bisphosphonate treatment of children and adolescents].
Illum NO
Ugeskr Laeger; 2003 Jan; 165(5):454-6. PubMed ID: 12599842
[No Abstract] [Full Text] [Related]
18. Bisphosphonate treatment of bone disease.
Shaw NJ; Bishop NJ
Arch Dis Child; 2005 May; 90(5):494-9. PubMed ID: 15851432
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates: mode of action and pharmacology.
Russell RG
Pediatrics; 2007 Mar; 119 Suppl 2():S150-62. PubMed ID: 17332236
[TBL] [Abstract][Full Text] [Related]
20. [Diphosphonates. Current trends and therapeutic prospects].
Raviolo P; Galvagno G; Biarese V; Lovisetto P
Clin Ter; 1989 Apr; 129(1):31-41. PubMed ID: 2525450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
